If considering the use of a GLP-1, set realistic expectations and maximize their effectiveness with these tips: Medications like semaglutide or tirzepatide deliver clinically meaningful weight loss over time
GLP-1 RAs are being studied [archived link] for use in many other medical conditions, including fatty liver disease, Parkinsons disease, and substance use disorders, among others
For now though, weekly injection is the standard
We also need to evaluate other tools, such as the FRAX and trabecular bone score (TBS) in this specific population
The search terms used included GLP-1 agonists, Glucagon-Like Peptide-1 Receptor Agonists, semaglutide, Ozempic, Wegovy, liraglutide, bone health, orthopedic surgery, arthroplasty, post-operative complications, complications, bone health, bone strength, osteogenesis, and bone metabolism. To ensure the relevance and quality of the studies, we established specific inclusion and exclusion criteria